[1] Stöcklin G, Pike V W . Radiopharmaceuticals for positron emission tomography. Developments in Nuclear Medicine, Kluwer Academic Publishers , 1993
[2] Comar D .
PET for drug development and evaluation
. Developments in Nuclear Medicine (PH, C, Ed), 1995[3] Wagner H N, Burns H D, Dannals R F, et al . Science, 1983, 221:1264
[4] Farde L, Hall H, Ehrin E, et al . Science, 1986, 23:258
[5] Mukherjee J, Christian B T, Dunigan K A, et al . Synapse, 2002, 46:170
[6] Swahn C G, Halldin C, Guenther I, et al . J Labelled Compd Radiopharm, 1996, 40: 675
[7] Ametamey S M, Halldin C, Swahn C G, et al . Nucl Med Biol 1995, 22:959
[8] Poyot T, Conde F, Gregoire M C, et al . J Cereb Blood Flow Metab, 2001, 21:782
[9] Laakso A, Bergman J, Haaparanta M, et al . Synapse, 1998, 28:244
[10] Pike V W, Halldin C, McCarron J A, et al . Eur J Nucl Med, 1998, 25:338
[11] Passchier J, van Waarde A, Pieterman R M, et al . Nucl Med Biol, 2000, 27:473
[12] Ito H, Nyberg S, Halldin C, et al . J Nucl Med, 1998, 39:208
[13] Biver F, Wikler D, Lotstra F, et al . Br J Psychiatry, 1997, 171444
[14] Blin J, Sette G, Fiorelli M, et al . J Neurochem, 1990, 54:1744
[15] Szabo Z, Kao P F, Scheffel U, et al . Synapse, 1995, 20:37
[16] Houle S, Ginovart N, Hussey D, et al . Eur J Nucl Med, 2000, 27:1719
[17] Bischof Delaloye A . Eur J Nucl Med, 2002, 29:13
[18] Huang Y, Bae S A, Zhu Z, et al . J Labelled Compd Radiopharm, 2001, 44:18
[19] Huang Y, Hwang D R, Narendran R, et al . J Cereb Blood Flow Metab, 2002, 22: 1398
[20] Hamill T G, Krause S, Ryan C, et al . Synapse, 2005, 56:205
[21] Ametamey S M, Kessler L J, Honer M, et al . J Nucl Med 2006, 47:698
[22] Farde L, Halldin C, Stone-Elander S, et al . Psychopharmacology, 1987, 92: 278
[23] Abi Dargham A, Martinez D, Mawlawi O, et al . J Cereb Blood Flow Metab, 2000, 20:225
[24] Olsson H, Halldin C, Swahn C G, et al . J Cereb Blood Flow Metab, 1999, 19: 1164
[25] Wong D F, Yung B, Dannals R F, et al . Synapse, 1993, 15:130
[26] Chaly T, Dhawan V, Kazumata K, et al . Nucl Med Bio, 1996, 23:999
[27] Goodman M M, Kilts C D, Keil R, et al . Nucl Med Bio, 2000, 27:1
[28] Carson R E, Lang L, Watabe H, et al . Nucl Med Biol, 2000, 27: 493
[29] Fowler J S, Volkow N D, Wang G J, et al . Proc Natl Acad Sci USA, 1996, 93:14065
[30] Fowler J S, MacGregor R R, Wolf A P, et al . Science, 1987, 235:481
[31] Fowler J S, Wang G J, Volkow N D, et al . Am J Psychiatry, 2000, 157:1864
[32] Pappata S, Samson Y, Chavoix C, et al . J Cereb Blood Flow Metab, 1988, 8: 304
[33] Iyo M, Itoh T, Yamasaki T, et al . Neuropharmacology, 1991, 30:207
[34] Leveque P, Labar D, Gallez B Nucl Med Biol, 2001, 28:809
[35] Doll F, Dolci L, Valette H, et al . J Med Chem, 1999, 42:2251
[36] Valette H, Bottlaender M, Dolle F, et al . J Nucl Med, 1999, 40:1374
[37] Burn D J, Rinne J O, Quinn N P, et al . Brain, 1995, 118:951
[38] Theodore W H, Carson R E, Andreasen P, et al . Epilepsy Res, 1992, 13:129
[39] Frost J J, Douglass K H, Mayberg H S, et al . J Cereb Blood Flow Metab, 1989, 9: 398
[40] Sandell J, Halldin C, Hall H, et al . Nucl Med Biol, 1999, 26:159
[41] Koeppe R A, Frey K A, Kume A, et al . J Cereb Blood Flow Metab, 1997, 17: 919
[42] Bauer A, Holschbach MH, Meyer P T, et al . Neuroimage, 2003, 19:1760
